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Introduction: 
 Periodontitis is a disease of the periodontium characterized by inflammation of the 
gums and breakdown of the supporting structures of teeth.  Periodontitis can be classified as 
aggressive or chronic periodontitis.  Aggressive periodontitis is characterized by rapid 
attachment loss and bone destruction, and its patients are usually adolescents who are 
clinically healthy except for the presence of periodontitis (Lang et al, 1999).  Chronic 
periodontitis is characterized by slow to moderate rate of progression and it is commonly 
detected in adults.  Both disease entities can be further classified in terms of the number of 
sites involved (localized or generalized).  If less than 30% of sites are affected, it is defined as 
localized.  If more than 30% of sites are affected, it is defined as generalized. (Lindhe et al, 
1999).   
The initiation of periodontitis occurs when predominantly gram-negative, anaerobic 
or microaerophilic bacteria colonize the subgingival area. (Page, 1997)  At the 1996 World 
Workshop on Clinical Periodontics, the relevant working group concluded that most human 
periodontitis is caused by Porphyromonas gingivalis, Bacteroids forsythus and Actinobacillus 
actinomycetemcomitans.  While the etiology of periodontitis is bacterial, the pathogenesis of 
disease is mediated by the host response.  In general, the colonization of bacteria stimulates 
the host defense mechanism against infection, which produces a variety of host molecules to 
neutralize the bacterial challenge. (Kornman, 1997)  However, the host system, which is 
normally protective, causes tissue damage when the balance between the host system and 
bacteria is disrupted. (Page, 1997) 
The balance between host defense mechanisms and bacteria can be disrupted when 
periodontal bacteria overcome the protective mechanism of human body, mainly provided by 
epithelial barriers, antibodies, complement proteins and neutrophils (Hart et al, 1994; 
Miyasaki et al, 1991).  There are several ways for periodontal bacteria to overcome these 
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protective host mechanisms.  First of all, some bacteria, such as A. actinomycetemcomitans or 
Campylobacter rectus, produce leukotoxins that kill neutrophils directly (Tsai et al, 
1979;Gillespie, Smutko et al,1993).  Secondly, some bacteria, such as P. gingivalis, produce 
proteolytic enzymes that reduce the level of antibody and complement proteins (Cutler, 
Arnold, Schenkein et al, 1993; Schenkein et al, 1989).  Third, some bacteria such as A. 
actinomycetemcomitans produce factors that suppress the immune response (Shenker, Vitale, 
Welham et al, 1990; Shenker, Tsai, Taichman et al, 1982).  Finally, some bacteria invade 
tissue cells so that they can avoid contact with neutrophils and molecules of immune system 
(Fives-Taylor, Meyer, Mintz et al, 1995; Lamont, Chan, Belton, Izutsu et al, 1995; Holt and 
Brammanti, 1991).  Increased and persistent levels of microorganisms and the consequent 
production of its metabolic by-products affect the gingival vasculature and provide the 
environment and nutrients that allow putative pathogens to flourish. (Moore and Moore. 
1994)  As a result, more virulent microorganisms become concentrated within the plaque 
mass.   
Once the major protective elements in the periodontium have been overwhelmed by 
bacteria, a number of host-mediated destructive processes are also initiated.  First of all, 
neutrophil-mediated tissue injury occurs.  Polymorphonuclear leukocytes, which normally 
provide protection, contribute to tissue damage by spilling some of proteolytic enzymes 
during degranulation process, which, in turn, degrade surrounding host cells (Van Dyke, 
2003). Moreover, bacterial constituents such as lipopolysaccharide (LPS) engages with 
monocytes, lymphocytes, fibroblast, and other host cells and stimulate production of both 
catabolic cytokines and inflammatory mediators including arachidonic acid metabolites such 
as prostaglandin E2 (PGE2).  Such cytokines and inflammatory mediators in turn cause the 
release of tissue-derived enzymes, the matrix metalloproteinases and the mobilization of the 
host tissues, and results in establishment of tissue destruction in periodontitis lesions 
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(Offenbacher, 1996; Birkedal-Hansen, 1993).  In this process, cytokines are crucial in 
molecular signaling, and are responsible for inflammatory changes related with periodontal 
disease by affecting the metabolism of many other surrounding tissues. 
 Among cytokines released from surrounding host cells, interleukin I (IL-1) has some 
of the most significant effects.  IL-1 is a very potent multifunction cytokine that appears to be 
a central regulator of the inflammatory and immune responses.  It has numerous effects on 
bone.  It increases inflammatory cell recruitment and inhibits bone formation, by binding to 
osteoblast cells.   The effects of IL-1 on ostetoblasts include stimulation of prostaglandin 
formation and modulation of gene expression of several proteins, such as cytokines, enzymes, 
enzyme inhibitors, matrix proteins, and so forth. (Tatakis, 1993)  This suggests that IL-1 may 
be involved in the pathogenesis of bone disease, and previous studies of periodontitis using 
IL-1 and Tumor Necrosis Factor (TNF) antagonists confirms that significant component of 
the pathologic process of periodontitis is due to IL-1/TNF activity. (Graves et al., 1998) 
The production and activity of IL-1 is regulated by both transcriptional and 
posttranslational mechanisms, as well as by the IL-1 receptor antagonist (IL-1ra).  IL-1ra 
counterbalances the potentially injurious proinflammatory effects of IL-1β.  Functional 
polymorphisms in IL-1B promoter region could impair the interplay between IL-1 and IL-
1ra, causing an unfavorable high IL-1/IL-1ra ratio.  Several polymorphisms were identified in 
the IL-1B region, including -511 and -31 in the promoter region, and +3954 in exon 5. 
(Bioque et al, 1995; Di Giovine et al, 1992; Pociot et al, 1992)  It has been indicated that -511 
and -31 polymorphisms inducing unfavorable IL-1/IL-1ra ratio influences higher 
susceptibility to and prognosis of diseases possibly due to IL-1β-mediated inflammation. 
(Moos et al, 2000; El-Omar et al, 2000; Bioque et al, 1995)  In terms of periodontitis 
occurrence, a previous study has shown the association of single nuclear polymorphisms at 
IL-1B-511 with periodontitis occurrence, while IL-1B-3954 was not significantly associated. 
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(Emecen et al, under review)  However, previous studies imply that the effects of the 
promoter SNPs on gene transcription and regulation could involve many interactions among 
multiple polymorphic sites as a complex. (Terry et al., 2000; Drysdale et al., 2000; Daly et 
al., 2001)  Therefore, we have used a case-control approach to study the association of 
haplotypes in the region of the interleukin 1 gene with generalized aggressive periodontitis 
and generalized chronic periodontitis in a Turkish population. 
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Materials and Methods: 
Study subjects 
A cross-sectional study design was used with patients who registered for treatment at 
Hacettepe University, Faculty of Dentistry, Department of Periodontology.  The study 
protocol was approved by the Ethics Committee of Hacettepe University Medical Sciences 
Review Board and the Ohio State University Biomedical Institutional Review Board.  
Informed consent was obtained from all participants in accordance with the Helsinki 
Declaration. 
 The study population included three groups; generalized aggressive periodontitis 
(GAP), generalized chronic periodontitis (GCP) patients and periodontally healthy controls 
(HC) diagnosed by criteria based on AAP’s 1999 International Workshop for a Classification 
of Periodontal Diseases and Conditions.  In the present study, 52 generalized aggressive 
patients, 53 generalized chronic patients, and 42 periodontally healthy controls were 
evaluated for 3 IL-1B gene polymorphisms.  Two of these, IL-1B -31 and IL-1B -511, are 
located on the promoter region, and one, IL-1B +3954, on the 5th exon.  
All participants were non-smokers and had at least 20 teeth in the mouth.  None of 
them had a serious systemic disease impairing the immune system.  Exclusion criteria also 
included medical disorders like diabetes that will affect periodontal pathogenesis, pregnancy 
and lactating.  Diagnoses were confirmed by periapical or panoramic radiographs and 
periodontal examination performed by a single examiner.  The clinical measurements 
included measurement of probing depth (PD), clinical attachment loss (CAL), plaque index 
(PI) and bleeding on probing (BOP).  Probing depth and CAL were measured at six locations 
around each tooth and median measurement was calculated and used for comparisons.  
Plaque index was recorded according to Sillness and Loe (1964), while BOP was recorded as 
percentage of bleeding sites compared total available tooth surfaces.  
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Isolation of genomic DNA 
Genomic DNA was extracted from peripheral blood samples by using a salting out 
procedure (Miller, 1986). The PCR amplifications were performed in 50 µl volume. The 
primer selection and PCR amplification were carried out according to Kornman et al. (1997).  
DNA (100-500 ng) was mixed with 48 µl of Supermix, 1 µl of forward and reverse primer, 1 
µl of distilled water.  The enzyme digestion was carried out by mixing 17 µl of PCR product 
with 10U of corresponding restriction enzyme and incubating for 16 hours at 37°C. 
IL-1B-31:  The SNP at position 31 of IL-1B gene was amplified using the thermocycling 
conditions of denaturation for 2 min at 96 °C followed by 35 cycles of denaturation for 1 min 
at 94 °C, annealing of primers for 1 min at 50 °C, primer extension for 1 min at 72 °C and 
final extension for 2 min at 72 °C.  The PCR products were digested with 10U of Alu I 
endonuclease at 37 °C for 16 hours.  The resulting PCR products 83bp+150bp (allele 1,T) 
and 234bp (allele 2, C) were visualized on 3% agarose gel electrophoresis as 125V for 45 
min, which contains ethidium bromide for staining.  The heterozygous individuals were 
identified by the presence of two bands. 
IL-1B-511: The SNP at position -511 of IL-1B gene was amplified using the thermocycling 
conditions of denaturation for 2 min at 95 °C followed by 35 cycles of denaturation for 1 min 
at 94 °C, annealing of primers for 1 min at 53 °C, primer extension for 1 min at 74 °C and 
final extension for 5 min at 72 °C.  The PCR products were digested with 10U of Ava I 
endonuclease at 37 °C for overnight.  The resulting PCR products 190bp+114bp (allele 1, C) 
and 304bp (allele 2, T) were visualized on 3% agarose gel electrophoresis as 130V for 30 min 
and ethidium bromide staining.  The heterozygous individuals were identified by the presence 
of three bands. 
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IL-1B +3954: The SNP at position +3954 of IL-1B gene was amplified using the 
thermocycling conditions of denaturation for 2 min at 95 °C followed by 35 cycles of 
denaturation for 1 min at 95 °C, annealing of primers for 1 min at 67.5 °C, primer extension 
for 1 min at 74 °C and final extension for 2 min at 72 °C.  The PCR products were digested 
with 10U of Taq I endonuclease at 65 °C for overnight.  The resulting PCR products 
97bp+85bp+12bp (allele 1, C) and 184bp+12bp (allele 2, T) were visualized on 4% agarose 
gel electrophoresis as 130V for 30 min and ethidium bromide staining.  The heterozygous 
individuals were identified by the presence of three bands. 
 
Data Analysis:  
The allele association and allele frequencies in GAP, GCP and HC groups were 
analyzed by using the Chi-Square test.  The different haplotypes and distribution of haplotype 
frequencies between groups were determined using HelixTree software trial package.  This 
program uses the Expectation-Maximization (EM) algorithm and the Composite Haplotype 
Method algorithm to calculate haplotype frequencies with 95% confidence interval.  The EM 
algorithm provides the maximum likelihood estimates of the frequencies of haplotypes 
(Excoffier and Slatkin, 1995). 
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Results: 
Allele frequencies of IL-1β SNPs in GAP case, GCP case and control groups 
IL-1β polymorphisms were detected at positions -31, -511, and +3954 in the GAP 
case, GCP case and healthy control groups.  The allele frequencies for these three SNPs in 
the GAP case and GCP case groups were not significantly different from those observed in 
the control group (Table 2, Table 3).  There was an over-representation of -31C and -511T in 
the GAP case group relative to the control group, but the differences between case and 
control groups were not statistically significant (P = 0.13 and P=0.063, respectively). 
 
Analysis of allele association 
The significance of the association between each of the three IL-1β SNPs and 
case/control status was examined.  The -31T>C and -511C>T SNPs exhibited a significant 
association with GAP cases (P = 0.024 and P = 0.017, respectively), but there was no 
apparent association between +3954C>T and GAP (Table 4).  None of these SNPs exhibited 
a significant association with GCP (Table 5). 
 
Haplotype analysis 
Haplotype frequency analysis delineated seven haplotypes for subjects in the GAP 
group, six haplotypes in the GCP group and five haplotypes in the control group (Table 6).  
The four most common haplotypes found in all groups were -31C/-511T/+3954C, -31T/-
511C/+3954C, -31T/,-511C/+3954T and -31C/-511T/+3954T.  The most common haplotype 
in the GCP group and the control group was -31T/-511C/+3954C, while the most common 
haplotype in the GAP group was -31C/-511T/+3954C.   
With respect to -31C/-511T/+3954C and -31C/-511T/+3954T haplotypes, the 
frequencies observed in the GAP group were higher than those observed in the GCP or 
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control groups.  However, with respect to -31T/-511C/+3954C and -31T/-511C/+3954T 
haplotypes, the frequencies observed in the GAP group were lower than those observed in the 
GCP or control groups.   
In both GAP and GCP groups, no haplotypes had significantly different frequency 
from the control group when comparing 95% confidence interval range of EM frequencies 
(Figure 1).  All comparisons showed the overlap of 95% confidence interval range of EM 
frequencies between the case and the control group. 
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Discussion: 
 Since Kornman et al. (1997) reported an association between IL-1 polymorphisms in 
the promoter region and adult periodontitis, several other studies have attempted to confirm 
this relationship.  Many of these studies concentrated on the single nucleotide polymorphisms 
IL-1A +4845 and IL-1B +3954 on chromosome 2q.13.  However, the results from several 
studies were not consistent, and it has not been possible to find the truly causative agent of 
periodontitis from the individual single nucleotide polymorphism approach. For example, 
Parkhill et al. (2000) and Diehl et al. (1999) reported that the homozygotes of allele 1 of IL-
1B +3954 had an increased risk of developing aggressive periodontitis, while Lopez et al. 
(2005) found that the carriage of homozygous for allele 1 of IL-1B +3954 appeared to be a 
protective factor for periodontitis, and the heterozygous genotype of the IL-1B +3954 showed 
a strong positive association with periodontitis.  According to Knight (2005), the single 
nucleotide polymorphism approach is likely to mislead unless the SNP itself can be a 
sufficient etiological event or a reliable marker of a disease-related haplotype. 
 Since an understanding of haplotype structure across segments of chromosomes that 
contain potential disease genes is likely to increase the value of genetic association (Horne et 
al, 2004; Crawford et al, 2005; Tabor et al, 2002), in the present studies, we chose two other 
SNPs to investigate among SNPs identified in the IL1B gene by Chen et al. (2006), along 
with IL-1B +3954 SNP..  Previous haplotype analysis papers in IL-1B gene were reviewed 
(Wen et al, 2006; Hall et al, 2004; El-Omar et al, 2000; Chen et al, 2006), and SNPs at IL-1B 
-31 and -511 were chosen to be analyzed together with IL-1B +3954 SNP for the IL-1B 
promoter function of individual SNPs alone and within the haplotype sequences. 
 In a single SNP analysis, IL-1B -31T>C SNPs was associated with GAP (P=0.024).  
This is the first report on the association between IL-1B -31 SNP and periodontitis risk.  In 
the GAP group, subjects who had IL-1B -31T/T genotype exhibited lower frequencies than 
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the control group, and subjects who had IL-1B -31T/C genotype exhibited higher frequencies 
than the control group.  No significant difference was found from the distribution of allele 
frequencies at IL-1B -31. 
At position IL-1B -511, its genotype also exhibited a significant association with GAP 
(P=0.017).  The homozygous pair of C allele decreased, and the heterozygous pair of T allele 
and C allele increased significantly in GAP group, which is consistant with the male GAP 
group of Chinese population from Li et al. (2004).  Li et al. (2004) reported that the IL-1B -
511 T/C heterozygote frequency was significantly increased in the male GAP group 
compared to male controls with marginal evidence for association (P=0.048), while there was 
no statistically significant difference in the distribution of the genotypes and alleles at IL-1B -
511 between GAP and control groups.  No significant difference was found from the 
distribution of allele frequencies at IL-1B -511. 
 There were no statistically significant differences in the distributions of the genotypes 
and alleles for IL-1B +3954 among three groups, which is contradict with many of previous 
papers (Parkhill et al, 2000; Diehl et al, 1999; Lopez et al, 2005; Rogers et al, 2002; Quappe 
et al, 2004).  
 In our haplotype analysis, no significant differences between case and control groups 
were detected with respect to the predominant haplotypes.  However, we detected the 
increase of the frequency from two haplotypes which contain rare alleles at -31 and -511, -
31C/-511T/+3954C and -31C/-511T/+3954T, and the decrease of the frequency from two 
haplotypes containing common alleles at -31 and -511, -31T/-511C/+3954C and -31T/-
511C/+3954T.  One possible explanation of this trait is that IL-1B-31 and IL-1B -511 are in 
essentially complete linkage disequilibrium in all populations of which we are aware (El-
Omar et al, 2000; Lee et al, 2004; Muraki Y et al, 2004; Hall et al, 2004).  This combination 
may be an example of two SNPs that evolved together as a result of biological activity based 
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on a cis-interaction (Guasch et al. 1996).  This linkage disequilibrium can be related with the 
allele frequency analysis from our study.  Both the IL-1B -31C allele and the IL-1B -511T 
allele was overrepresented in the GAP group relative to the control group although this was 
not statistically significant (P=0.13 and P=0.063 respectively). 
 In ex vivo studies of LPS-induced IL-1β secretion, Hall et al. (2004) reported that the 
IL-1B haplotype, composed of -31C and -511T allele, was significantly associated with a 2-3 
fold increase in LPS-induced IL-1β protein secretion.  In addition, it seems to be associated 
with enhanced release of newly synthesized IL-1β protein, which is consistent with our 
findings.  However, Wen et al. (2006) reported that IL-1β level was higher in homozygotes 
of the -31T-511C haplotype from the analysis with use of the haplotype containing only the -
31 and -511 polymorphisms, which contradicts the report from Hall et al. (2004).  One 
possible reason for the disagreement is the difference of the population.  Hall et al. (2004) 
examined 31 healthy controls and 24 white subjects with rheumatoid arthritis, while Wen et 
al. (2006) examined 105 healthy subjects only.  Ex vivo studies with periodontitis subjects 
and healthy controls is a reasonable approach for the further study for correlation with case-
control studies.  
 In conclusion, polymorphisms in IL-1B -31 and -511 may contribute to the risk of 
developing GAP, while IL-1B +3954 polymorphisms do not appeared to be associated with 
an increased risk of developing periodontitis in a Turkish population.  From the haplotype 
analysis, none of detected haplotypes was significantly associated with periodontitis risk, 
even though haplotypes with -31C and -511T exhibited higher frequencies in the GAP group.  
Further haplotype analysis with other SNPs in IL-1B is recommended due to the possibility 
that the causative agents throughout the IL-1 cluster on the 2q.13 region could be in linkage 
disequilibrium with -31C and -511T. 
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Table 1. Primers for Analysis of IL-1B polymorphisms 
 
Polymorphisms Primers 
IL-1B -31 Forward-TCTTTTCCCCTTTCCTTTAACT 
 Reverse-GAGAGACTCCCTTAGCACCTAGT 
  
IL-1B -511 Forward-TGGCATTGATCTGGTTCATC 
 Reverse-GTTTAGGAATCTTCCCACTT 
  
IL-1B +3954 Forward-CTCAGGTGTCCTCGAAGAAATCAAA 
 Reverse-GCTTTTTTGCTGTGAGTCCCG 
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Table 2. Allele frequencies of IL-1B SNPs in generalized aggressive periodontitis (GAP) 
and control groups 
 
SNP  GAP 
n   (freq) 
Control 
n    (freq) 
P value* 
 
IL-1ß  -31 T 52     (0.50)     51     (0.62) 0.130 
 C 52     (0.50) 31     (0.38)   
     
IL-1ß  -511 C 48     (0.46) 50     (0.61) 0.063 
 T 56     (0.54) 32     (0.39)  
     
IL-1ß +3954 C 79     (0.76) 63     (0.77) 0.972 
 T 25     (0.24) 19    (0.23)  
* Chi-Square test 
 
 
 
 
 
 
 
 
 
 
Table 3.  Allele frequencies of IL-1B SNPs in generalized chronic periodontitis (GCP) 
and control groups 
 
SNP  GCP 
n    (freq) 
Control 
n    (freq) 
P value* 
IL-1ß  -31 T 70     (0.66)  51     (0.62) 0.695 
 C 36     (0.34) 31     (0.38)   
     
IL-1ß  -511 C 71     (0.67) 50     (0.61) 0.484 
 T  35     (0.33)  32     (0.39)  
     
IL-1ß +3954 C 74    (0.70) 63     (0.77) 0.364 
 T 32    (0.30) 19    (0.23)  
* Chi-Square test 
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Table 4. Allele association of IL-1B SNPs with generalized aggressive periodontitis 
(GAP) 
 
SNP  GAP 
n   (freq) 
Control 
n    (freq) 
P value* 
 
IL-1ß  -31 TT 10     (0.19) 18     (0.44) 0.024 
 TC 32     (0.62)  15     (0.37)   
 CC 10     (0.19) 8      (0.19)  
     
IL-1ß  -511 CC 8      (0.15) 17     (0.41) 0.017 
 TC 32     (0.62)  16      (0.39)  
 TT 12     (0.23) 8       (0.20)  
     
IL-1ß +3954 CC 30    (0.58) 26     (0.63) 0.528 
 TC 19     (0.36) 11    (0.27)  
 TT 3     (0.06) 4      (0.10)  
* Chi-Square test 
 
 
 
 
 
 
 
 
Table 5. Allele association of IL-1B SNPs with generalized chronic periodontitis (GCP) 
 
SNP  GCP 
n    (freq) 
Control 
n    (freq) 
P value 
 
IL-1ß  -31 TT 23     (0.43) 18     (0.44) 0.481 
 TC 24     (0.46)  15     (0.37)   
 CC 6      (0.11) 8      (0.19)  
     
IL-1ß  -511 CC 23     (0.44) 17     (0.41) 0.355 
 TC  25     (0.47)  16      (0.39)  
 TT 5      (0.09) 8       (0.20)  
     
IL-1ß +3954 CC 27    (0.51) 26     (0.63) 0.467 
 TC 20    (0.38) 11    (0.27)  
 TT 6      (0.11) 4      (0.10)  
* Chi-Square test 
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Table 6. IL-1B haplotype frequencies in generalized aggressive periodontitis, 
generalized chronic periodontitis and control groups 
 
Haplotype IL-1B GAP Control GCP 
(-31, -511, +3954) Mean C.I. Mean C.I. Mean C.I. 
C,T,C 0.401 0.073 0.379 0.085 0.328 0.071 
T,C,C 0.269 0.061 0.387 0.100 0.383 0.085 
T,C,T 0.144 0.057 0.193 0.086 0.248 0.076 
C,T,T 0.078 0.048 0.028 0.046 0.014 0.036 
T,T,C 0.077 0.059 0.013 0.038 nd nd 
C,C,C 0.025 0.032 nd nd nd nd 
C,C,T 0.005 0.027 nd nd 0.018 0.032 
T,T,T Nd nd nd nd 0.009 0.028 
* The Expectation-Maximization algorithm was used to calculate mean value and confidence 
interval. 
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Figure 1. Range of EM frequencies of common haplotypes of groups in 95% confidence 
interval 
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* Group 1 is GAP group, Group 2 is control group, and Group 3 is GCP group.  The mean 
value of EM frequencies is drawn as horizontal block, and 95% confidence interval of EM 
frequencies is drawn as a vertical line. 
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